Akèy › Skleroz Miltip › Florid
Etid klinik pou Skleroz Miltip nan Florid
14 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Florid.
Vil nan Florid
Tèks ofisyèl etid la (Anglè)
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Aqualane Clinical Research, Naples
- USF Health, Tampa
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Oct 1, 2026 · NCT06782490A Study of Ocrelizumab Administered Subcutaneously in Participants With Multiple Sclerosis Who Switch From an Approved Anti-CD20 Therapy
- Neurology Associates, PA, Maitland
Ap rekriteFaz 4
Laj 18 a 65 · Tout sèks · Mizajou Sep 30, 2026 · NCT07609719A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Altamonte Springs
- TG Therapeutics Investigational Trial Site, Boca Raton
- TG Therapeutics Investigational Trial Site, Clearwater
- ak 7 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752Clinical Applications of Advanced Ophthalmic Imaging
- Bascom Palmer Eye Institute, Miami
Ap rekriteVolontè an sante akeyi
Laj 18 a 99 · Tout sèks · Mizajou Sep 16, 2026 · NCT03135327Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Neurology of Central Florida- Site Number : 8400147, Altamonte Springs
- Aqualane Clinical Research- Site Number : 8400026, Naples
- Neurology Associates of Ormond Beach- Site Number : 8400086, Ormond Beach
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of South Florida, Department of Psychiatry and Behavioral Neuroscience, Tampa
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- University of South Florida, Tampa
Ap rekriteFaz 3
Laj 10 a 17 · Tout sèks · Mizajou Sep 10, 2026 · NCT06408259A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neurology of Central FL Res Ctr, Altamonte Springs
- UF Health Cancer Center, Gainesville
- Homestead Assoc In Research Inc, Homestead
- ak 8 plis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Neurologic Stem Cell Treatment Study
- MD Stem Cells, Coral Springs
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 26, 2026 · NCT02795052Dry Needling in Multiple Sclerosis
- University of South Florida, Tampa
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou May 29, 2026 · NCT07615725Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
- Norman Fixel Institute for Neurological Diseases, Gainesville
- University of Florida, Gainesville
Ap rekrite
Laj 18 a 100 · Tout sèks · Mizajou Mar 6, 2026 · NCT07376772Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
- University of St. Augustine for Health Sciences, Saint Augustine
Ap rekriteVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou May 20, 2025 · NCT06981013Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
- Mayo Clinic Jacksonville, Jacksonville
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 18 a 80 · Tout sèks · Mizajou May 2, 2025 · NCT05395624Longitudinal Cognitive Assessment by BoCA
- Andrey Vyshedskiy, Miami
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 50 ak plis · Tout sèks · Mizajou Aug 1, 2024 · NCT04114994Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.